Streetbeat News

Equity Actions

DXC

DXC Technology (NYSE:DXC) has been evaluated by 4 analysts over the past three months, with a shift towards a more bearish stance. The average 12-month price target has been lowered by 12.38% to $23.00, with a high estimate of $24.00 and a low of $21.00. Analysts from JP Morgan, Citigroup, BMO Capital, and RBC Capital have all lowered their price targets. DXC Technology's financial performance shows a decline in revenue growth, below-average net margin and ROE, and a high debt-to-equity ratio, indicating potential financial challenges.

Portfolio Pulse from Benzinga Insights

January 24, 2024 | 6:00 pm

MMM

Five analysts have recently updated their ratings on 3M (NYSE:MMM), with four maintaining an indifferent stance and one rating it as somewhat bearish. The average 12-month price target is now $103.2, up from $102.60, with individual analysts adjusting their targets both upwards and downwards. 3M's financials show a revenue decline of -3.56%, a high net margin of -24.96%, an ROE of -33.28%, an ROA of -4.21%, and a debt-to-equity ratio of 3.6, indicating mixed financial health and potential risks.

Portfolio Pulse from Benzinga Insights

January 24, 2024 | 6:00 pm

MGNX

Macrogenics (NASDAQ:MGNX) received mixed reviews from 5 analysts, with recent ratings ranging from bullish to somewhat bullish. The average 12-month price target is $14.00, a significant increase from the previous $10.33. Analysts from JMP Securities, Citigroup, Stifel, HC Wainwright & Co., and Guggenheim have adjusted their price targets and ratings, reflecting changes in market dynamics and company performance. Macrogenics, a biotech company specializing in antibody-based cancer therapeutics, has a market cap below industry benchmarks and experienced a significant revenue decline of -75.09% over the last quarter. However, it has a high net margin of 168.84%, an ROE of 9.6%, and an ROA of 5.44%, indicating strong profitability and financial management.

Portfolio Pulse from Benzinga Insights

January 24, 2024 | 6:00 pm

AMZN

BABA

DKNG

FIVE

GCT

GENI

MELI

NKE

TSLA

Whale activity in the Consumer Discretionary sector indicates large volumes of options trading, with notable transactions in TSLA, AMZN, BABA, DKNG, M, GENI, NKE, MELI, FIVE, and GCT. The sentiment of these trades varies, with bearish and bullish positions taken on different stocks, and significant amounts of money involved in each transaction.

Portfolio Pulse from Benzinga Insights

January 24, 2024 | 5:35 pm

CAVA

Cava Group (NYSE:CAVA) has seen a 26.01% decrease in short interest since its last report, with 9.59 million shares sold short, representing 8.76% of its float. The average time to cover these short positions is 4.47 days. While a decrease in short interest can indicate a more bullish sentiment, it does not necessarily predict a near-term rise in stock price. Cava Group's short interest is slightly higher than its peer group average of 8.42%.

Portfolio Pulse from Benzinga Insights

January 24, 2024 | 5:15 pm

AMZN

On CNBC, Stephanie Link announced that she has increased her investment in Amazon.com, indicating a positive outlook on the company's stock.

Portfolio Pulse from Benzinga Newsdesk

January 24, 2024 | 5:03 pm

MOS

Four analysts have recently updated their ratings on Mosaic (NYSE:MOS), showing a mix of indifference and slight bullishness. The average 12-month price target is now $36.25, down 6.26% from previous estimates, with a high of $42.00 and a low of $34.00. Analysts from Mizuho, Wells Fargo, Barclays, and RBC Capital have adjusted their price targets and ratings, reflecting a nuanced view of Mosaic's market position. Mosaic, a major phosphate and potash producer, has seen a -33.66% decline in revenue growth and faces profitability challenges with a net margin of -0.12% and ROE of -0.03%. Despite this, Mosaic maintains a healthy debt-to-equity ratio of 0.32.

Portfolio Pulse from Benzinga Insights

January 24, 2024 | 5:00 pm

CSIQ

Analyst ratings for Canadian Solar (NASDAQ:CSIQ) show mixed sentiments with a decrease in the average 12-month price target from $43.00 to $32.40. Brian Lee of Goldman Sachs raised the target from $25.00 to $28.00, maintaining a 'Neutral' rating. Jon Windham of UBS and Colin Rusch of Oppenheimer lowered their targets, with 'Buy' and 'Outperform' ratings, respectively. Mark Strouse of JP Morgan also lowered his target, assigning an 'Underweight' rating. Canadian Solar's financial health shows a negative revenue trend, a high net margin, and challenges in debt management.

Portfolio Pulse from Benzinga Insights

January 24, 2024 | 5:00 pm

UBER

Uber Technologies (NYSE:UBER) has seen a 15.09% rise in short interest since the last report, with 84.71 million shares sold short, representing 4.27% of available shares. It would take about 4 days to cover all short positions based on current trading volume. While an increase in short interest can indicate bearish sentiment, it doesn't necessarily predict a price drop. Uber's short interest is below its peer group average of 10.15%.

Portfolio Pulse from Benzinga Insights

January 24, 2024 | 5:00 pm

BTCUSD

GBTC

Grayscale's Bitcoin Trust (GBTC) has transferred over 100K BTC to exchanges since the launch of spot Bitcoin ETFs on Jan. 11. The majority of these transfers were to Coinbase Prime for sale. GBTC reduced its management fee to 1.50%, still higher than competitors, leading to over $1 billion in daily AUM outflows. Bitcoin's price fell below $40,000, influenced by these sales and other factors. FTX's sale of 22 million GBTC shares did not slow the outflow.

Portfolio Pulse from Benzinga Newsdesk

January 24, 2024 | 4:59 pm